Cover Image
市場調查報告書

玻尿酸市場分析:各產品 (單劑,三劑,五劑) 、各應用 (骨關節炎,抗組織沾黏,藥物遞輸,皮膚填充劑) 、各市場區隔的預測

Hyaluronic Acid Market Analysis By Product (Single Injection, Three Injection, Five Injection), By Application (Osteoarthritis, Adhesive Prevention, Drug Delivery, Dermal Fillers) And Segment Forecasts To 2020

出版商 Grand View Research, Inc. 商品編碼 342334
出版日期 內容資訊 英文 61 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
玻尿酸市場分析:各產品 (單劑,三劑,五劑) 、各應用 (骨關節炎,抗組織沾黏,藥物遞輸,皮膚填充劑) 、各市場區隔的預測 Hyaluronic Acid Market Analysis By Product (Single Injection, Three Injection, Five Injection), By Application (Osteoarthritis, Adhesive Prevention, Drug Delivery, Dermal Fillers) And Segment Forecasts To 2020
出版日期: 2015年02月15日 內容資訊: 英文 61 Pages
簡介

全球玻尿酸市場預測將在2020年前達到108億美元的規模。未來方面,人體組織工程,再生醫療領域上玻尿酸的新適用性,可望提供市場有利的成長機會。

本報告提供全球玻尿酸市場相關調查分析,提供您各產品,各應用,各地區的預測,加上主要企業相關的系統性資訊。

第1章 摘要整理

第2章 玻尿酸產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場動態
    • 推動市場要素分析
    • 阻礙市場要素分析
  • 優先的主要機會
  • 產業分析
  • PESTEL分析

第3章 玻尿酸的各產品預測

  • 單劑量
  • 3次給藥
  • 五劑

第4章 玻尿酸的各應用預測

  • 骨關節炎
  • 眼科
  • 皮膚填充劑
  • 膀胱輸尿管逆流現象

第5章 玻尿酸的各地區預測

  • 北美
    • 各產品
    • 各應用
  • 歐洲
    • 各產品
    • 各應用
  • 亞太地區
    • 各產品
    • 各應用
  • 其他
    • 各產品
    • 各應用

第6章 競爭情形

  • 企業簡介 (企業概要,財務實際成果,產品基準,策略性構想)
    • Allergan Inc
    • Sanofi (Genzyme)
    • Anika Therapeutics Inc.
    • Salix Pharmaceuticals
    • Dentsply International Inc.
    • 生化學工業
    • F.Hoffmann-La Roche Ltd.
    • Galderma S.A
    • Zimmer Holdings Inc
    • Smith & Nephew plc
    • Ferring Pharmaceuticals Inc.

圖表

目錄

Global hyaluronic acid market is expected to reach USD 10.80 billion by 2020. Growing incidence rates of gingivitis, ulcers, osteoarthritis and geriatric population base is expected to serve this market as high impact rendering drivers. Hyaluronic acid's novel applicability in the fields of tissue engineering and regenerative medicine is expected to present the market with lucrative future growth opportunities.

Five-injection was the leading product segment, accounting for over 35.0% of the market in 2013. High usage rates associated with this treatment is one of the primary factors attributing to its large share. However, the market is expected to experience a growth in demand for low risk and cost effective treatments. Consequently, the single-injection cycle is expected to grow at an attractive rate over the next six years. The segment, on account of its advantages offers enhanced patient convenience and is therefore, expected to witness improved compliance.

Further key findings from the study suggest:

Dermal fillers were the largest application segment and its market was valued at over USD 2.0 billion in 2013. Recent improvements in the field of anti-aging and high compatibility of hyaluronic acid with the human body are some factors expected to drive segment growth during the forecast period.

North America was the largest regional market in 2013 majorly on account of growing incidence rates of target diseases, geriatric population base and the presence of high patient awareness levels pertaining to anti-aging procedures.

Asia Pacific is identified as the most lucrative region of this market. Growing demand for medical tourism and rapidly improving healthcare infrastructure in the emerging markets of India and China are some factors attributing to its rapid growth. Presence of high patient unmet needs and improving economic conditions in the region is also expected to assist manufacturers in capitalizing on the available untapped opportunities.

Some key market players of the hyaluronic acid market include Anika Therapeutics Inc., F. Hoffmann-La Roche Ltd., Allergan Inc, Zimmer Holdings Inc, Ferring Pharmaceuticals Inc., Sanofi (Genzyme), Zimmer Holdings Inc and Salix Pharmaceuticals.

Manufacturers in an attempt to ensure sustainability engage in extensive R&D aimed at developing cost effective and technologically advanced products. For instance, the introduction of a pill version of hyaluronic acid and the re-launch of hyaluronic acid serum with additional vitamin infusion

For the purpose of this study, Grand View Research has segmented the global hyaluronic acid market on the basis of product, application and region:

Global Hyaluronic Acid Product Outlook (Revenue, USD Billion, 2012 - 2020)

  • Single injection
  • Three injection
  • Five injection

Global Hyaluronic Acid Application Outlook (Revenue, USD Billion, 2012 - 2020)

  • Osteoarthritis
  • Ophthalmic
  • Dermal fillers
  • Vesicoureteral reflux

Hyaluronic Acid Regional Outlook (Revenue, USD Billion, 2012 - 2020)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • RoW

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Hyaluronic Acid - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Hyaluronic Acid Industry Outlook

  • 2.1. Market Segmentation
  • 2.2. Market Size and Growth Prospects
  • 2.3. Hyaluronic Acid Market Dynamics
    • 2.3.1. Market Driver Analysis
    • 2.3.2. Market Restraint Analysis
  • 2.4. Key Opportunities Prioritized
  • 2.5. Industry Analysis - Porter's
  • 2.6. Hyaluronic Acid Market PESTEL Analysis, 2013

Chapter 3. Hyaluronic Acid Product Outlook

  • 3.1. Single Injection
    • 3.1.1. Single Injection Market Estimates and Forecasts, 2012 - 2020 (USD Million)
  • 3.2. Three Injection
    • 3.2.1. Three Injection Market Estimates and Forecasts, 2012 - 2020 (USD Million)
  • 3.3. Five Injection
    • 3.3.1. Five Injection Market Estimates and Forecasts, 2012 - 2020 (USD Million)

Chapter 4. Hyaluronic Acid Application Outlook

  • 4.1. Osteoarthritis
    • 4.1.1. Osteoarthritis Market Estimates and Forecasts, 2012 - 2020 (USD Million)
  • 4.2. Ophthalmic
    • 4.2.1. Ophthalmic Market Estimates and Forecasts, 2012 - 2020 (USD Million)
  • 4.3. Dermal Fillers
    • 4.3.1. Dermal Fillers Market Estimates and Forecasts, 2012 - 2020 (USD Million)
  • 4.4. Vesicoureteral Reflux
    • 4.4.1. Vesicoureteral Reflux Market Estimates and Forecasts, 2012 - 2020 (USD Million)

Chapter 5. Hyaluronic Acid Regional Outlook

  • 5.1. North America
    • 5.1.1. Hyaluronic acid Market Estimates and Forecasts, by Product, 2012 - 2020 (USD Million)
      • 5.1.1.1. U.S.
      • 5.1.1.2. Canada
    • 5.1.2. Hyaluronic acid Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million)
      • 5.1.2.1. U.S.
      • 5.1.2.2. Canada
  • 5.2. Europe
    • 5.2.1. Europe Hyaluronic acid Market Estimates and Forecasts, by Product, 2012 - 2020 (USD Million)
      • 5.2.1.1. UK
      • 5.2.1.2. Germany
    • 5.2.2. Europe Hyaluronic acid Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million)
      • 5.2.2.1. UK
      • 5.2.2.2. Germany
  • 5.3. Asia Pacific
    • 5.3.1. Asia Pacific Hyaluronic acid Market Estimates and Forecasts, by Product, 2012 - 2020 (USD Million)
      • 5.3.1.1. China
      • 5.3.1.2. Japan
    • 5.3.2. Hyaluronic acid Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million)
      • 5.3.2.1. China
      • 5.3.2.2. Japan
  • 5.4. RoW
    • 5.4.1. RoW Hyaluronic acid Market Estimates and Forecasts, by Product, 2012 - 2020 (USD Million)
    • 5.4.2. RoW Hyaluronic acid Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million)

Chapter 6. Competitive Landscape

    • 6.1. Allergan Inc
      • 6.1.1. Company Overview
      • 6.1.2. Financial Performance
      • 6.1.3. Product Benchmarking
      • 6.1.4. Strategic Initiatives
    • 6.2. Sanofi (Genzyme)
      • 6.2.1. Company Overview
      • 6.2.2. Financial Performance
      • 6.2.3. Product Benchmarking
      • 6.2.4. Strategic Initiatives
    • 6.3. Anika Therapeutics Inc.
      • 6.3.1. Company Overview
      • 6.3.2. Financial Performance
      • 6.3.3. Product Benchmarking
      • 6.3.4. Strategic Initiatives
    • 6.4. Salix Pharmaceuticals
      • 6.4.1. Company Overview
      • 6.4.2. Financial Performance
      • 6.4.3. Product Benchmarking
      • 6.4.4. Strategic Initiatives
    • 6.5. Dentsply International Inc.
      • 6.5.1. Company Overview
      • 6.5.2. Financial Performance
      • 6.5.3. Product Benchmarking
      • 6.5.4. Strategic Initiatives
    • 6.6. Seikagaku Corporation.
      • 6.6.1. Company Overview
      • 6.6.2. Financial Performance
      • 6.6.3. Product Benchmarking
      • 6.6.4. Strategic Initiatives
    • 6.7. F.Hoffmann-La Roche Ltd.
      • 6.7.1. Company Overview
      • 6.7.2. Financial Performance
      • 6.7.3. Product Benchmarking
      • 6.7.4. Strategic Initiatives
    • 6.8. Galderma S.A
      • 6.8.1. Company Overview
      • 6.8.2. Financial Performance
      • 6.8.3. Product Benchmarking
      • 6.8.4. Strategic Initiatives
    • 6.9. Zimmer Holdings Inc
      • 6.9.1. Company Overview
      • 6.9.2. Financial Performance
      • 6.9.3. Product Benchmarking
      • 6.9.4. Strategic Initiatives
    • 6.10. Smith & Nephew plc
      • 6.10.1. Company Overview
      • 6.10.2. Financial Performance
      • 6.10.3. Product Benchmarking
      • 6.10.4. Strategic Initiatives
    • 6.11. Ferring Pharmaceuticals Inc.
      • 6.11.1. Company Overview
      • 6.11.2. Financial Performance
      • 6.11.3. Product Benchmarking
      • 6.11.4. Strategic Initiatives

List of Tables

  • Global Hyaluronic acid Market - Industry Summary & Critical Success Factors (CSFs)
  • Global Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • Global Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • Global Hyaluronic acid Market, by Region, 2012 - 2020 (USD Million)
  • Hyaluronic acid - Key Market Driver Analysis
  • Hyaluronic acid Market - Key Market Restraint Analysis
  • North America Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • U.S. Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • Canada Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • North America Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • U.S. Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • Canada Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • Europe Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • UK Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • Germany Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • Europe Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • UK Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • Germany Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • Asia Pacific Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • China Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • Japan Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • Asia Pacific Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • China Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • Japan Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)
  • RoW Hyaluronic acid Market, by Product, 2012 - 2020 (USD Million)
  • RoW Hyaluronic acid Market, by Application, 2012 - 2020 (USD Million)

List of Figures

  • Global Hyaluronic acid Market Segmentation
  • Global Hyaluronic acid Market Revenue, (USD Million), 2012 - 2020
  • Hyaluronic acid Market Dynamics
  • Hyaluronic acid Market - Porter's Analysis
  • Key opportunities prioritized
  • Hyaluronic acid Market - PESTEL Analysis
  • Global Hyaluronic acid Market Revenue Share by Product, 2013 & 2020
  • Global Hyaluronic acid Market Revenue Share by Application, 2013 & 2020
  • Global Hyaluronic acid Market Revenue Share by Region, 2013 & 2020
  • North America Hyaluronic acid Market, 2012 - 2020 (USD Million)
  • Europe Hyaluronic acid Market, 2012 - 2020 (USD Million)
  • Asia Pacific Hyaluronic acid Market, 2012 - 2020 (USD Million)
  • RoW Hyaluronic acid Market, 2012 - 2020 (USD Million)
Back to Top